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Lysophospholipid Receptor-Mediated Calcium
Signaling in Human Keratinocytes
Karin Lichte1, Roberto Rossi1, Kerstin Danneberg1, Michael ter Braak1, Ulrich Ku¨rschner2, Karl H. Jakobs1,
Burkhard Kleuser2 and Dagmar Meyer zu Heringdorf1
The lysophospholipids, sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA), stimulate chemotaxis
and induce differentiation of human keratinocytes. As Ca2þ plays an important role in keratinocyte
differentiation, we studied Ca2þ signaling by S1P and LPA in these cells, known to express mRNA transcripts
of the S1P15 and LPA13 receptors, and the receptor subtypes involved in this process. S1P and LPA caused
transient increases in intracellular free Ca2þ concentration ([Ca2þ ]i), with pEC50 values of 8.5±0.11 and
7.5±0.23, respectively. The [Ca2þ ]i increases are apparently mediated by stimulation of phospholipase C and
involve Ca2þ mobilization from thapsigargin-sensitive stores and subsequent Ca2þ influx. The LPA-induced
[Ca2þ ]i increases were not inhibited by the LPA1/3 receptor antagonist, dioctanoylglycerol pyrophosphate. The
S1P-induced [Ca2þ ]i increases were largely inhibited by the putative S1P3 antagonist, BML-241, and the S1P1/3
antagonist, VPC23019. The S1P1-specific agonist, SEW2871, did not increase [Ca
2þ ]i but stimulated chemotaxis of
keratinocytes, which was fully blocked by S1P1 antisense oligonucleotides. The data indicate that LPA and S1P
potently increase [Ca2þ ]i in human keratinocytes and that the effect of LPA is mediated by LPA2, whereas that of
S1P is mediated at least to a large part by S1P3. The S1P1 receptor, without stimulating [Ca
2þ ]i increases,
mediates chemotaxis of keratinocytes.
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INTRODUCTION
The lysophospholipids, sphingosine-1-phosphate (S1P) and
lysophosphatidic acid (LPA), are ubiquitous autocrine and
paracrine mediators regulating cell growth and survival,
differentiation, cell motility, adhesion, and intracellular free
Ca2þ concentrations ([Ca2þ ]i) in many cell types (for
reviews, see Spiegel and Milstien, 2003; Tigyi and Parrill,
2003; Anliker and Chun, 2004; Sanchez and Hla, 2004;
Rosen and Goetzl, 2005; Gardell et al., 2006). S1P plays a
decisive role for vascular maturation and regulates angiogen-
esis, vascular tone and permeability, heart rate, trafficking of
lymphocytes, and tumour cell growth (Spiegel and Milstien,
2003; Anliker and Chun, 2004; Sanchez and Hla, 2004;
Rosen and Goetzl, 2005; Visentin et al., 2006). LPA regulates
implantation, contributes to the development of the nervous
system, has an antiadipogenic activity, and plays a role in
inflammation and arteriosclerosis (Tigyi and Parrill, 2003;
Anliker and Chun, 2004; Siess and Tigyi, 2004; Simon et al.,
2005; Ye et al., 2005). Other physiological or pathophysio-
logical roles for lysophospholipids have been suggested. The
above-mentioned actions of S1P and LPA are mediated by a
network of specific G protein-coupled receptors, of which the
receptors of the endothelial differentiation gene family,
S1P15 and LPA13, have been characterized in greatest
detail (Tigyi and Parrill, 2003; Anliker and Chun, 2004;
Sanchez and Hla, 2004; Rosen and Goetzl, 2005). Two other,
more distantly related G protein-coupled LPA receptors and
three more putative S1P receptors have furthermore been
identified (Uhlenbrock et al., 2002; Noguchi et al., 2003; Lee
et al., 2006). In addition, LPA acts intracellularly as a weak
activator of the ligand-activated transcription factor, peroxi-
some proliferator-activated receptor-g, whereby it promotes
neointima formation (McIntyre et al., 2003; Zhang et al.,
2004). S1P, independently of its role as agonist at G protein-
coupled receptors, also functions as intracellular second
messenger and thereby transduces signals of diverse recep-
tors; however, its intracellular target sites have not been
identified so far (reviewed in Spiegel and Milstien, 2003;
Meyer zu Heringdorf, 2004).
Sphingolipids have long been recognized as important
structural components of the epidermis, securing the
epidermal permeability barrier. Moreover, recent findings
suggest a substantial role of S1P and LPA as bioactive
molecules in keratinocytes involved in the regulation of cell
growth and differentiation. Although S1P and LPA are potent
mitogens in a variety of cells, an opposite effect is apparent in
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human keratinocytes, as both mediators inhibit growth of the
epidermal cells. However, S1P and LPA do not drive
keratinocytes into apoptosis but rather induce their differ-
entiation as assessed by transglutaminase activity (Manggau
et al., 2001; Vogler et al., 2003; Sauer et al., 2004b). S1P and
LPA also induce migration of keratinocytes to denuded areas
of the culture dish, implying a role of these lipids in the re-
epithelialization of wounds.
It is well established that the extracellular Ca2þ concen-
tration is an important regulator of keratinocyte differentia-
tion in vitro (Hennings et al., 1980; Watt et al., 1984). An
early response to an increase in the extracellular Ca2þ
concentration is an increase in [Ca2þ ]i (Hennings et al.,
1989; Pillai et al., 1990). Most interestingly, blocking the rise
in [Ca2þ ]i with intracellular Ca
2þ chelators inhibits the
differentiation process, suggesting that [Ca2þ ]i increases are
important in initiating the differentiation of keratinocytes (Li
et al., 1995). As S1P and LPA are potent inductors of
keratinocyte differentiation, it was of great interest to further
elucidate the role of the lipid mediators on Ca2þ signaling in
these cells. Moreover, the first lysophospholipid receptor
subtype-specific compounds have become available recently
(Parrill et al., 2004). Therefore, we studied Ca2þ signaling by
lysophospholipids in human keratinocytes and analyzed the
involved lysophospholipid receptor subtypes. In addition, we
compared the effects of the receptor subtype-specific
compounds in human keratinocytes to those in HEK-293
(human embryonic kidney) cells, as these cells have been
used before for the analysis of lysophospholipid-mediated
Ca2þ signaling (van Koppen et al., 1996; Meyer zu
Heringdorf et al., 2001, 2003b).
RESULTS AND DISCUSSION
In agreement with previous reports demonstrating that S1P
and LPA induce keratinocyte differentiation, the two lysopho-
spholipids increased mRNA levels of the differentiation
markers, keratin 1, keratin 10, and involucrin (Table 1). Both
S1P and LPA caused transient [Ca2þ ]i increases in adherent
human keratinocytes loaded with fluo-4 (Figure 1). In
concentrations maximal for activation of G protein-coupled
lysophospholipid receptors, S1P and LPA caused rapid
[Ca2þ ]i peaks followed by a more sustained phase of [Ca
2þ ]i
elevation, which slightly differed in shape between groups of
cells and lasted 1–3minutes (Figures 1a, b, and e, Figures 3
and 4). Concentrations of S1P just above threshold caused
[Ca2þ ]i increases with a variable delay, some cells did not
respond (Figures 1d and g). A perinuclear vesicular compart-
ment in keratinocytes did not accumulate fluo-4 (Figures 1f
and g), which, together with confocal microscopy, allowed to
easily differentiate between [Ca2þ ]i increases in nuclei and
cytoplasm. In most cells, basal fluo-4 fluorescence was
slightly higher in the nucleus than in the cytosol and
increased to a higher extent after stimulation, although any
changes in [Ca2þ ]i in the cytosol were paralleled by the same
changes in the nucleus (Figure 1c).
For determination of concentration–response relationships
of lysophospholipid-induced [Ca2þ ]i increases, we used
detached cells that could be measured in suspension with
the ratioable compound, fura-2 (Figure 2). S1P and LPA
increased [Ca2þ ]i with pEC50 values of 8.5±0.11 (Hill slope
0.47±0.05; mean±SEM; n¼ 4–5) and 7.5±0.23 (Hill
slope 0.51±0.13; mean±SEM; n¼3), respectively. The
S1P-related lysophospholipid, sphingosylphosphorylcholine
(SPC), increased [Ca2þ ]i with pEC50 of 5.8±0.03 (Hill slope
1.44±0.12; mean±SEM; n¼ 3). Maximum [Ca2þ ]i
increases by S1P, LPA, and SPC in suspended cells were
252±33 nM (mean±SEM; n¼13), 401±30 nM (mean±SEM;
n¼4), and 291±49 nM (mean±SEM; n¼4), respectively.
The EC50 values for [Ca
2þ ]i increases by S1P and SPC in
keratinocytes are in the same range as in other cell types, for
example, in HEK-293 and vascular endothelial cells (Meyer
zu Heringdorf et al., 1996; van Koppen et al., 1996), with S1P
being two to three orders of magnitude more potent than SPC.
These data suggest that, in keratinocytes, SPC increases
[Ca2þ ]i by acting as a low-affinity agonist at S1P receptors, as
it has been shown for recombinant S1P1, S1P2, and S1P3
receptors (reviewed in Meyer zu Heringdorf et al., 2002),
rather than by activating a high-affinity SPC receptor such as
OGR-1, which mediates [Ca2þ ]i increases by SPC in the
nanomolar range (Xu et al., 2000). It is of particular interest
that keratinocytes respond to SPC, as this lipid has been
shown to accumulate in the stratum corneum in patients with
atopic dermatitis (Okamoto et al., 2003).
[Ca2þ ]i increases by S1P were caused by mobilization of
Ca2þ from intracellular stores and concomitant Ca2þ influx
(Figure 3). In suspended cells, peak [Ca2þ ]i increases by 1 mM
S1P in the absence of extracellular Ca2þ reached
33.3±6.4% of those in the presence of 1mM extracellular
Ca2þ (mean±SEM; n¼ 4; Figure 3a). After incubation of
keratinocytes in Ca2þ -free medium, the re-addition of 1mM
Ca2þ increased [Ca2þ ]i by 248±45 nM (mean±SEM; n¼ 3).
When the cells had been challenged with 1 mM S1P in Ca2þ -
free medium, the re-addition of 1mM Ca2þ increased [Ca2þ ]i
by 403±66 nM (mean±SEM; n¼3), and thus Ca2þ influx by
S1P was 63% higher than Ca2þ influx caused by incubation
in Ca2þ -free medium alone (Figure 3a). In adherent cells,
peak [Ca2þ ]i increases were not much diminished in the
absence of extracellular Ca2þ , indicating that the overall
[Ca2þ ]i increase induced by S1P in adherent cells was largely
due to Ca2þ mobilization (Figure 3b); however, elevated
[Ca2þ ]i returned back to baseline values much faster in the
absence of extracellular Ca2þ .
In keratinocytes, the intracellular Ca2þ compartments of
endoplasmic reticulum and Golgi apparatus seem to function
Table 1. mRNA levels of differentiation markers in
human primary keratinocytes in response to 1 lM S1P
and 1 lM LPA relative to cyclophilin A
S1P LPA
Keratin 1 108.6±29.3 122.0±22.4
Keratin 10 31.6±1.7 85.7±7.3
Involucrin 11.4±1.2 8.2±1.9
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relatively separately, as mutations in sarco-endoplasmic
reticulum Ca2þ -ATPase-2, a Ca2þ pump of endoplasmic
reticulum, and secretory pathway Ca2þ -ATPase-1, pumping
Ca2þ into the Golgi apparatus, cause the different pheno-
types of Darier’s and Hailey–Hailey disease, respectively
(Behne et al., 2003; Dhitavat et al., 2004). Furthermore, the
secretory pathway Ca2þ -ATPase-1-dependent Ca2þ stores
in keratinocytes are of functional importance for agonist
(ATP)-induced [Ca2þ ]i increases (Callewaert et al., 2003).
Therefore, we studied the influence of the sarco-endoplasmic
1 µM S1P
10 nM S1P
10 µM LPA
1 nM S1P
300
250
200
150
100
50
0
9
8
7
6
5
4
3
2
1
0
1 µM S1P
7 12.5
10.0
7.5
5.0
2.5
0.0
10
8
6
4
2
0
6
5
4
3
2
1
0
60 120 180
Time (seconds)
240 300
60 120 180
Time (seconds)
240 300
600 120 180
Time (seconds)
600 120 180
Time (seconds)
600 120 180 240
20 µm
20 µm
Time (seconds)
Control 1 nM S1P 
8 seconds
1 nM S1P 
21 seconds
1 µm lonomycin 
24 seconds
240 300
Fl
uo
-4
 fl
uo
re
sc
en
ce
 (F
/F
0)
Fl
uo
-4
 fl
uo
re
sc
en
ce
 (F
/F
0)
Fl
uo
-4
 fl
uo
re
sc
en
ce
 (F
/F
0)
Fl
uo
-4
 fl
uo
re
sc
en
ce
Fl
uo
-4
 fl
uo
re
sc
en
ce
 (F
/F
0)1 µM lonomycin
1 µM lonomycin 1 µM lonomycin
1 µM lonomycin
Cytosol
Nucleus
Figure 1. [Ca2þ ]i increases by S1P and LPA in adherent keratinocytes. Keratinocytes grown on glass coverslips were loaded with fluo-4 and analyzed
by confocal fluorescence microscopy. (a–e) The mean fluorescence in defined regions of interest, each line representing a single cell and each graph
representing a group of cells measured in parallel. The cells were challenged with the indicated concentrations of S1P, LPA, and ionomycin. In (c), fluo-4
fluorescence was measured separately in the nucleus and the cytosol of one cell. Note that, in (c), for better comparison, fluorescence within the two
compartments was not normalized to basal fluorescence. (f) High-resolution fluorescence image of a group of fluo-4-loaded keratinocytes. (g) Fluorescence
images taken from a typical measurement, before (control) and at the indicated times after addition of 1 nM S1P or 1 mM ionomycin.
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reticulum Ca2þ -ATPase inhibitor, thapsigargin, on [Ca2þ ]i
increases by S1P and LPA in keratinocytes. After pretreatment
for several minutes with thapsigargin, which by itself caused
transient [Ca2þ ]i increases (Figure 4a), neither S1P nor LPA
were able to elevate [Ca2þ ]i, indicating that they released
Ca2þ from endoplasmic reticulum (Figures 4b and c).
Furthermore, [Ca2þ ]i increases by S1P were inhibited by
pretreatment with pertussis toxin. After incubation with
100 ngml1 pertussis toxin for 16 hours, [Ca2þ ]i increases
by S1P were 8.9±2.9% of control (mean±SD, n¼6),
indicating the involvement of Gi proteins.
To study a possible involvement of phospholipase C
(PLC) in Ca2þ mobilization by lysophospholipids in
adherent keratinocytes, we used the phosphatidylinositol-
4,5-bisphosphate/inositol-1,4,5-trisphosphate (IP3) sensor,
cyan fluorescent protein (CFP)-PLCd1(PH) (Sinnecker and
Schaefer, 2004). The use of the PH domain of PLCd fused to
fluorescent proteins has been introduced as early as in 1998/
1999, at first to detect changes in phosphatidylinositol-4,
5-bisphosphate levels, then for the measurement of IP3
(Stauffer et al., 1998; Hirose et al., 1999). The suitability of
this fluorescent sensor for monitoring IP3 fluctuations in living
cells has been characterized in great detail (Okubo et al.,
2001; Xu et al., 2003; Bartlett et al., 2005). This technique
has since advanced the understanding of spatiotemporal
relationships between the PLC/IP3 pathway and Ca
2þ
signaling (for review, see Nahorski et al., 2003). As shown
in Figure 5, 10 mM LPA (Figure 5a) and 1 mM bradykinin (Figure
5c) caused a decrease of CFP-PLCd1(PH) fluorescence in the
plasma membrane, accompanied by an increase of fluores-
cence in the cytosol. S1P (1 mM) also induced this process
(Figure 5b), indicating that the lysophospholipids, S1P and
LPA, stimulated phosphatidylinositol-4,5-bisphosphate
hydrolysis and IP3 generation in keratinocytes. S1P, further-
more, caused a rapid enlargement of the cells, which led to
an initial small decrease in cytosolic fluorescence before
translocation of CFP-PLCd1(PH) increased cytosolic fluores-
cence as in the case of LPA and bradykinin (Figure 5b). These
results were confirmed by IP3 measurements. LPA (10 mM) and
S1P (1mM) increased cellular IP3 levels by 2.0±0.29-fold and
1.5±0.16-fold within 20 seconds, respectively (mean±SEM;
n¼3). Both PLC-dependent and PLC-independent Ca2þ
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Figure 2. Concentration–response curves of lysophospholipid-induced
[Ca2þ ]i increases in keratinocytes. The cells were detached, loaded with
fura-2, and [Ca2þ ]i was measured in suspended cells using a
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Figure 3. Analysis of S1P-induced [Ca2þ ]i increases in the absence and
presence of extracellular Ca2þ . (a) Fura-2 loaded cells in suspension were
challenged with 1 mM S1P in the presence of 1mM CaCl2 (þCa2þ ) or in
Ca2þ -free Hank’s balanced salt solution containing 50mM EGTA (Ca2þ ),
and increases in [Ca2þ ]i caused by S1P were measured (mobilization). In the
experiments performed in Ca2þ -free buffer, 1mM CaCl2 was re-added to cells
stimulated previously (Ca2þ -free/S1P/CaCl2 addition) or not (Ca
2þ -free/CaCl2
addition) with 1 mM S1P, and [Ca2þ ]i increase caused by Ca
2þ re-addition
was measured (influx). The data represent mean±SEM of four (mobilization)
or three (influx) independent experiments. (b) Adherent keratinocytes loaded
with fluo-4 were challenged with 1 mM S1P in Ca2þ -free medium. Typical
courses of [Ca2þ ]i after stimulation with 1 mM S1P are shown. The dotted
line represents measurements in the presence of 1mM CaCl2 from the same
set of experiments.
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mobilization has been shown with S1P and LPA. LPA
increased [Ca2þ ]i in neuroblastoma cells without stimulating
IP3 production (Young et al., 1999, 2000). The same was
observed with S1P, for example, in endothelial cells and
HEK-293 cells (Meyer zu Heringdorf et al., 1996, 2001). In
these cells, Ca2þ mobilization is apparently mediated by
intracellular S1P, generated by a rapid and transient
sphingosine kinase activation (discussed in Meyer zu
Heringdorf, 2004). In keratinocytes, however, both lipids
stimulated phosphatidylinositol-4,5-bisphosphate hydrolysis
and IP3 generation as in several other cell types.
Keratinocytes express mRNA transcripts of the S1P
receptors, S1P15, and the LPA receptors, LPA13 (Vogler
et al., 2003; Sauer et al., 2004b). For identification of the LPA
receptor(s) inducing [Ca2þ ]i increases in keratinocytes, we
used dioctanoylglycerol pyrophosphate (DGPP 8:0), which is
a short-chain derivative of diacylglycerol pyrophosphate.
Signaling functions have been assigned to diacylglycerol
pyrophosphate in yeast and plants but not in higher animals
(reviewed in van Schooten et al., 2006). DGPP 8:0 is a
competitive antagonist at human LPA receptors, inhibiting
preferentially LPA3 (Ki B100 nM) and also LPA1 (Ki B7 mM),
but not LPA2 (Fischer et al., 2001; Sardar et al., 2002; Parrill
et al., 2004). Pre-incubation with 20 mM DGPP 8:0 shortly
before addition of LPA had no influence on [Ca2þ ]i increases
induced by 100nM LPA in adherent keratinocytes (Figure 6a).
On the other hand, in HEK-293 cells known to express LPA1
but not LPA2 (Meyer zu Heringdorf et al., 2001), DGPP 8:0
inhibited [Ca2þ ]i increases induced by 100nM LPA with a
pIC50 of 5.6±0.07 (mean±SEM; n¼5; Figure 6b). Further-
more, 10 mM DGPP 8:0 shifted the concentration–response
curve of LPA-induced [Ca2þ ]i increases in HEK-293 cells to
the right (Figure 6c), indicating competitive antagonism.
From these data, it is concluded that LPA-induced [Ca2þ ]i
increases in keratinocytes are most likely mediated by the
DGPP 8:0-insensitive LPA2 receptor, whereas those in HEK-
293 cells might be primarily mediated by LPA1.
For identification of the S1P receptor(s) inducing [Ca2þ ]i
increases in keratinocytes, we used the putative S1P3
antagonist, BML-241 (Koide et al., 2002), the S1P1 agonist,
SEW2871 (Sanna et al., 2004), and the S1P1/3 antagonist,
VPC23019 (Davis et al., 2005). BML-241 was identified by
searching a three-dimensional database with pharmacophore
models of S1P and subsequently shown to inhibit [Ca2þ ]i
increases mediated by S1P3 (10 mM BML-241 inhibitedB40%
of [Ca2þ ]i increases induced by 1 mM S1P), but not S1P1, in a
HeLa expression system (Koide et al., 2002). In adherent
keratinocytes, 50 mM BML-241 applied 1–2minutes before
S1P fully inhibited [Ca2þ ]i increases by 1 mM S1P but did not
block the response to 1 mM LPA (Figure 7a). In keratinocytes in
suspension, [Ca2þ ]i increase by 100 nM S1P in the presence
of 50 mM BML-241 was 36±5.7% (mean±SD; n¼4) of those
in control cells and thus not fully inhibited (Figure 7b). In
HEK-293 cells expressing S1P13 (Meyer zu Heringdorf et al.,
2001), BML-241 inhibited [Ca2þ ]i increases by 10 nM S1P
with a pIC50 of 5.0±0.18 (mean±SEM; n¼ 3) and a full
inhibition at 50 mM (Figure 7d). Analysis of the concentra-
tion–response curve of S1P-induced [Ca2þ ]i increase re-
vealed a non-competitive mode of inhibition at a BML-241
concentration of 50 mM (Figure 7c). The data obtained with
BML-241 must be regarded with caution, as it has been
shown recently that BML-241 also inhibits [Ca2þ ]i increases
by other G-protein-coupled receptors such as P2 and a1A
receptors, and it has been suggested that it might have
an influence on the process of Ca2þ signaling (Jongsma
et al., 2006).
SEW2871 is a S1P1 receptor-selective agonist that is
structurally unrelated to S1P (Sanna et al., 2004; Jo et al.,
2005). SEW2871 stimulated GTPgS binding to membranes of
S1P1-expressing CHO cells (EC50 B10 nM), but not to
membranes of cells expressing S1P25, and mimicked actions
6
5
4
3
2
1
0
5
4
3
2
1
0
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
0 60 120 180
120
 LPA 10 µM
 S1P  
1 µM
 S1P 1 µM
 LPA 10 µM
240
1µM TG
360
Time (seconds)
Control
7 min TG 1 µM
Control
10 min TG 1 µM
Time (seconds)
0 60 120 180
Time (seconds)
480 600
Fl
uo
-4
 fl
uo
re
sc
en
ce
 (F
/F
0)
Fl
uo
-4
 fl
uo
re
sc
en
ce
 (F
/F
0)
Fl
uo
-4
 fl
uo
re
sc
en
ce
 (F
/F
0)
Figure 4. Thapsigargin sensitivity of lysophospholipid-induced [Ca2þ ]i
increases in keratinocytes. [Ca2þ ]i was measured in adherent cells loaded
with fluo-4. (a) [Ca2þ ]i increases induced by 1mM thapsigargin (TG).
(b, c) [Ca2þ ]i increases induced by 1 mM S1P or 10 mM LPA in cells pretreated
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of S1P at S1P1, such as phosphorylation of extracellular
signal-regulated kinase and acutely transforming retrovirus
AKT activation of Rac, stimulation of cell migration, and
induction of S1P1 internalization (Sanna et al., 2004; Jo et al.,
2005). SEW2871 at 1 mM, a maximal concentration for
stimulation of GTPgS binding and extracellular signal-
regulated kinase phosphorylation (Sanna et al., 2004; Jo
et al., 2005), did not induce [Ca2þ ]i increases in adherent
keratinocytes (Figures 8a and c) and had no effect on [Ca2þ ]i
increases by subsequent addition of 1 mM S1P and 10mM LPA
(Figures 8b and d). However, SEW2871 stimulated migration
of keratinocytes measured in a modified Boyden chamber
with a maximum effective concentration of 1 mM (Figure 8e).
SEW2871-stimulated chemotaxis was fully abrogated by S1P1
antisense oligonucleotides (Figure 8e). This observation with
a specific S1P1 receptor agonist supports previous studies that
have shown that S1P-stimulated migration of keratinocytes
was strongly inhibited by pretreatment with S1P1 antisense
oligonucleotides (Sauer et al., 2004a). In HEK-293, SEW2981
(1 mM) similarly had no effect on resting [Ca2þ ]i but induced
internalization of overexpressed S1P1 receptor fused to green
fluorescent protein (GFP) (see Supplementary Information).
To overcome the concern that S1P1 expression levels might
be too low to detect measurable [Ca2þ ]i increases by
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Figure 5. Translocation of the CFP-tagged PH-domain of PLCd1 (CFP-PLCd1(PH)) by lysophospholipids in keratinocytes. Cells transfected with CFP-
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as the corresponding images. The time points specified on the images represent the time points at which they were taken. (b) After stimulation with
1mM S1P, cell shape always changed so that it was impossible to quantify CFP fluorescence in the plasma membrane.
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SEW2871, we analyzed [Ca2þ ]i in HEK-293 cells transiently
expressing S1P1-GFP. S1P1-GFP, which is a fully functional
S1P1 receptor (Liu et al., 1999), was localized at the plasma
membrane in HEK-293 cells where it was found in numerous
fine protrusions. SEW2871 did not induce [Ca2þ ]i increases
in S1P1-GFP-expressing cells. Furthermore, S1P1-GFP-
expressing cells, whether treated or not with SEW2871,
hardly responded to S1P with any [Ca2þ ]i increases
(Supplementary Information), in agreement with previous
observations suggesting an inhibitory rather than a stimula-
tory role of S1P1 in Ca
2þ signaling (Meyer zu Heringdorf
et al., 2003b). It is concluded that S1P1 did not contribute to
S1P-induced [Ca2þ ]i increases in keratinocytes.
VPC23019 was recently synthetized and characterized as
a competitive antagonist at S1P1 and S1P3 receptors (Davis
et al., 2005). Although it had no stimulatory effect on GTPgS
binding in membranes of HEK293T cells expressing S1P1 or
S1P3 by itself, VPC23019 caused a rightward shift of S1P-
stimulated GTPgS binding in these membranes and displaced
bound S1P (Davis et al., 2005). VPC23019 was reported to
have no effect on S1P2 (Davis et al., 2005). Addition of 10 mM
VPC23019 to adherent keratinocytes induced very small
increases in [Ca2þ ]i by itself and nearly fully inhibited
[Ca2þ ]i increases by subsequent addition of 100 nM S1P
(Figures 9a and b). In HEK-293 cells, VPC23019 caused a
rightward shift of the concentration–response curve of S1P-
induced [Ca2þ ]i increases (pEC50 8.5±0.17 (n¼ 4) and
7.4±0.24 (n¼3), respectively; mean±SEM; Figure 9c),
whereas it had no influence on [Ca2þ ]i increases by LPA
(Figure 9d). Furthermore, 10 mM VPC23019 inhibited the
internalization of S1P1-GFP induced by 100nM S1P (Figure
9e), which is in agreement with inhibition of S1P1 by
VPC23019 (Davis et al., 2005). As S1P1 did not contribute to
[Ca2þ ]i increases by S1P, it is concluded that [Ca
2þ ]i
increases by S1P in keratinocytes were mediated by S1P3.
Taken together, we have shown that the lysophospholi-
pids, S1P and LPA, not only regulate migration and
proliferation of human keratinocytes, but also potently
increase [Ca2þ ]i in these cells. Using newly available
compounds to analyze the lysophospholipid receptor sub-
types, we come to the conclusion that the Ca2þ -mobilizing
actions of S1P and LPA in keratinocytes are mainly mediated
by the S1P3 and LPA2 receptors, respectively. Further studies
are needed to clarify the exact role and contribution of
the observed [Ca2þ ]i increases to keratinocyte functional
responses.
MATERIALS AND METHODS
Materials
S1P, SPC, and BML-241 were from Biomol (Biomol GmbH,
Hamburg, Germany). LPA, bradykinin, and fatty acid-free BSA were
from Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany).
SEW2871 was purchased from Calbiochem/Merck Biosciences
GmbH (Schwalbach, Germany), whereas VPC23019 and DGPP
8:0 were from Avanti Polar Lipids Inc. (Alabaster, AL). Fura-2 and
Fluo-4 were obtained from Molecular Probes/Invitrogen GmbH
(Karlsruhe, Germany). All other materials were from previously
described sources (Ruwisch et al., 2001; Meyer zu Heringdorf et al.,
2003a, b; Vogler et al., 2003; Sauer et al., 2004a). Stock solutions of
S1P and SPC were made in methanol. Aliquots thereof were dried
down and dissolved in 1mgml1 fatty acid-free BSA. SEW2871 and
BML-241 were dissolved in dimethyl sulfoxide, DGPP 8:0 in
methanol, and LPA in H2O, and all were further diluted in H2O.
VPC23019 was dissolved in dimethyl sulfoxide/1 N HCl (95/5, v/v)
and further diluted in 1mgml1 fatty acid-free BSA. The respective
solvents were used as control.
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Figure 6. Influence of DGPP 8:0 on [Ca2þ ]i increases induced by LPA in
keratinocytes and HEK-293 cells. (a) [Ca2þ ]i was measured in adherent
keratinocytes loaded with fluo-4. The cells were treated with 20 mM DGPP 8:0
before addition of 100 nM LPA. (b, c) [Ca2þ ]i was measured in suspended
HEK-293 cells loaded with fura-2. The cells were treated for 2minutes with
the indicated concentrations of DGPP 8:0 or solvent before addition of LPA.
The data points represent mean±SEM of 2–4 independent experiments.
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Cell culture and transfection
Keratinocytes from human foreskin were isolated and cultivated as
described previously (Vogler et al., 2003). Briefly, the cells were
grown in serum-free keratinocyte growth medium (Cambrex
Corporation, now Lonza, Verviers, Belgium) containing bovine
pituitary extract, epidermal growth factor, insulin, hydrocortisone,
gentamicin, and amphotericin B (Vogler et al., 2003) in a humidified
atmosphere of 5% CO2/95% air at 371C. Transfection of keratino-
cytes was performed with Fugene 6 Transfection Reagent (Roche
Diagnostics GmbH, Applied Science, Mannheim, Germany) accord-
ing to the manufacturer’s instructions. For downregulation of the
S1P1 receptor, keratinocytes were transfected with oligonucleotides
as indicated for 3 days at a final concentration of 0.1 mM (S1P1
antisense oligonucleotides, 50-AGTGGACACCATAGCTGCTAA-30;
S1P1 control oligonucleotides, 5
0-TTAGCACGTATGGTGTCCACT-30).
Relative abundance of the S1P1 receptor protein expressed after
antisense oligonucleotide pretreatment was assessed by western blot
analysis. HEK-293 cells were cultivated and transfected as described
previously (Meyer zu Heringdorf et al., 2003b) and kept for 24 hours
in serum-free medium before experiments.
Quantitative real-time PCR
Keratinocytes were cultured in keratinocyte growth medium and
then stimulated with S1P (1 mM) or LPA (1mM) for 5 days. RNA was
collected using RNeasy kit (Qiagen GmbH, Hilden, Germany) and
cDNA was generated from total RNA using the FermentasAid First
strand cDNA synthesis kit (Fermentas GmbH, St Leon-Rot, Germany)
according to the manufacturer’s instructions. Quantitative real-time
PCR was performed using a LightCycler480 and the SYBR Green
PCR master mix (Roche Diagnostics GmbH). Cyclophilin A was used
as a normalization control for all experiments. For the measurement
of the differentiation markers keratin 1, keratin 10, and involucrin,
the following primers were used: keratin 1, CTATGGACAA
CAACCGCA (forward), CTTTGAATTTCTCACACTAT CCC (reverse);
keratin 10, AAGGAACTGACTACAGAAATTGATAATA (forward),
GCTGCACACAGTAGCGA (reverse); involucrin, GGAATTATTGTC
CAGTGCCA (forward), GGATTTATTATGTATCATTGTACACACTC
(reverse); cyclophilin A, TTTGCTTAATTCTACACAGTACTTAGAT
(forward), CTACCCTCAGGTGGTCTT (reverse). Total RNA of three
different sets of keratinocytes was used to analyze gene expression.
Data were obtained in triplicate and specific mRNA levels were
expressed as meanþ SEM relative to non-stimulated cells.
Measurement of intracellular Ca2þ concentration
In adherent cells, [Ca2þ ]i was measured by fluo-4 fluorescence
imaging as described previously (Meyer zu Heringdorf et al., 2003a).
Human keratinocytes or HEK-293 cells grown on glass coverslips
were loaded with 2mM fluo-4/AM for 30minutes. Measurements
were performed in Hank’s balanced salt solution (118mM NaCl,
5mM KCl, 1mM CaCl2, 1mM MgCl2, 5mM glucose, and 15mM
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Figure 7. Influence of BML-241 on [Ca2þ ]i increases induced by S1P in keratinocytes and HEK-293 cells. (a) [Ca
2þ ]i was measured in adherent keratinocytes
loaded with fluo-4. The cells were treated with BML-241, S1P, and LPA as indicated. (b–d): [Ca2þ ]i was measured in suspensions of (b) keratinocytes
or (c, d) HEK-293 cells loaded with fura-2. The cells were treated with the indicated concentrations of BML-241 or solvent before addition of S1P. The
values represent mean±SD, (b) n¼ 4 or (c, d) mean±SEM of 3–5 experiments.
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HEPES, pH 7.4) at room temperature. Fluo-4 fluorescence was
imaged with an inverted confocal laser scanning microscope (Zeiss
LSM510 or Leica TCS SP2). For excitation, the 488 nm line of an
argon laser was used, whereas emission was recorded at wave-
lengths above 505 nm. Mean fluorescence of single cells was
calculated by averaging regions of interest. Measurements of [Ca2þ ]i
with the ratioable dye, fura-2, were performed in a Hitachi F2000
spectrofluorometer using cells in suspension (Meyer zu Heringdorf
et al., 2003b). Briefly, monolayers of keratinocytes were detached
with trypsin and loaded with 1mM fura-2/AM in Hank’s balanced salt
solution for 1 hour at room temperature. Thereafter, the cells were
washed with Hank’s balanced salt solution, resuspended at a density
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of 1 106 cellsml1, and used for fluorescence measurements at
room temperature within the next hour.
Imaging of CFP and GFP fluorescence
The fluorescence of cells transfected with CFP-PLCd1(PH) or
S1P1-GFP was analyzed by confocal laser scanning microscopy
with a Zeiss LSM510 microscope and a  63/1.4 oil immersion
objective. CFP fluorescence was monitored with excitation at
458 nm and emission measured with a 475-nm-long pass filter.
GFP was analyzed with excitation at 488 nm and emission measured
with a 505–550 band pass filter.
Measurement of IP3 formation
Keratinocytes grown in 3.5 cm dishes were stimulated for 20 seconds
with 10 mM LPA, 1 mM S1P, or the respective vehicles. The reaction
was stopped with 0.5ml of 0.5 M trichloroacetic acid, and super-
natants were extracted three times with 3ml of water-saturated
diethyl ether. The neutralized samples (200ml) were complemented
with 50 ml of EDTA (30mM) and 50 ml of NaHCO3 (60mM). IP3 mass
was measured by competition with [3H]IP3 (PerkinElmer Life
and Analytical Sciences, Rodgau—Ju¨gesheim, Germany; 792
GBqmmol1) using IP3 binding protein prepared from bovine
adrenal cortex as described previously (Chilvers et al., 1991).
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Figure 9. Influence of VPC23019 on [Ca2þ ]i and localization of S1P1. (a, b) [Ca
2þ ]i was determined in adherent, fluo-4-loaded keratinocytes that were
challenged as indicated with VPC23019, S1P, and ionomycin. (c, d) Analysis of concentration–response curves of S1P- and LPA-induced [Ca2þ ]i increases
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Measurement of keratinocyte migration
Migration of keratinocytes in response to a gradient of SEW2871 was
measured in a modified Boyden chamber. The cells were added to
the upper wells of the chamber. The lower wells, separated by a
fibronectin-coated membrane, contained SEW2871 at the indicated
concentrations. The keratinocytes that had migrated through the
membrane were fixed, stained by GIEMSA, and quantified by light
microscopy at a magnification of  150 by counting the stained cells
from four randomly selected fields. All samples were tested in
triplicates and the data are expressed as the mean±SD. The specific
migration index following stimulation was calculated as the ratio
after setting the control vehicle random migration at 1.0.
Data presentation and analysis
Traces of [Ca2þ ]i and fluorescence images shown in the figures are
representative for at least three similar experiments. Averaged data
are mean±SEM from the indicated number (n) of experiments or
mean±SD from a representative experiment with the indicated
number (n) of replicates. Non-linear regression analysis of concen-
tration–response curves and statistical tests were performed using the
Prism program (GraphPad Software).
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